Tag Archives: Metastatic Castration-Resistant Prostate Cancer
Exploring the Potential of PSCA-Targeted Chimeric Antigen Receptor T-Cell Therapy in Order to Treat mCRPC
The mCRPC (Metastatic Castration-Resistant Prostate Cancer) remains a sort of deadly disease despite the improved treatment options for patients progressing […]
